While large and still awash in capital, the EV sector is, nevertheless, relatively young compared to other industries. So, ...
SoundHound AI ( SOUN 2.28%) is a leading developer of conversational artificial intelligence (AI). Its stock came public in ...
PDYN Stock Performance and Moving Averages. In recent trading, Palladyne AI Corp (PDYN) stock price has shown some volatility, fluctuating 241.78% over the last five trades and 89 ...
U.S. equities were higher at midday Friday, bouncing back from yesterday's selloff on optimism about growing demand for nuclear power and Tesla's recovery from its dip.
When Donald Trump takes office in less than three weeks, he'll be inheriting one of the priciest stock markets on record. The S&P 500's Shiller price-to-earnings (P/E) Ratio, also known as the ...
According to Fairlead Strategies founder Katie Stockton, the recent weakness in the stock market has flashed ... release of the S&P Case-Shiller home price index on Tuesday morning, followed ...
Wells Fargo has recently reduced Viridian Therapeutics Inc (VRDN) stock to Equal Weight rating, as announced on December 19, 2024, according to Finviz. Earlier, on November 25, 2024, TD Cowen had ...
Teledyne Technologies TDY +0.57% Get Free Report has outperformed the market over the past 20 years by 6.75% on an annualized ...
The analysts said they see a 28% upside for the stock and raised their price target to $140. They upgraded the stock to a Buy from a Sell recommendation. Goldman analysts cited "improving sales ...
Strong earnings growth Corporate earnings are the driving force behind rising stock prices in the long term, so it should be no surprise that LPL is watching for continued earnings strength in the ...
Veritone shares retreated Thursday after the company said it plans to purchase and sell more than 8 million shares of common stock for $2.53 a share. The stock was down 11% at $2.83 in morning trading ...
Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer PFE.N COVID-19 treatment Paxlovid, Bristol Myers Squibb's BMY.N cancer cell therapies and vaccines ...